Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 151 publications
Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.
Journal: Archives of pathology & laboratory medicine
Published: April 21, 2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 02, 2026
Intratumoral Expression of a Composite B Cell / CD8 T Cell Biomarker Stratifies Overall Survival by Circulating Tumor DNA Status and Benefit From Adjuvant Immunotherapy in High-Risk Muscle-Invasive Urothelial Carcinoma.
Journal: The Journal of urology
Published: October 27, 2025
Clinicopathologic and Prognostic Features of Sarcomatoid Urothelial Carcinoma: A Retrospective Study of 136 Patients With Emphasis on Early-Stage (pT1) Disease.
Journal: The American journal of surgical pathology
Published: September 15, 2025
Phase II Randomized Study of MK-2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG-ACRIN E2809).
Journal: The Prostate
Published: July 15, 2025
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma.
Journal: European urology
Published: June 12, 2025
Cost-Effectiveness of Perioperative Durvalumab With Neoadjuvant Gemcitabine/Cisplatin in Muscle-Invasive Bladder Cancer Treatment.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 18, 2025
Novel Pretreatment Autoantibodies Correlate with Enfortumab Vedotin-Related Dermatologic Events in Patients with Advanced Urothelial Cancer.
Journal: Cancer research communications
Published: January 30, 2025
Sarcomatoid areas of urothelial carcinoma are enriched for CD163-positive antigen-presenting cells.
Journal: The journal of pathology. Clinical research
Published: October 25, 2024
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: July 24, 2024
Last Updated: 09/26/2026